Position in DFTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,365,923
+$1,615,916 QoQ
Shares Held
50,296
+26.7% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 358 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DFTX Over Time
Shares Held
Position Value (USD)
Derivatives in DFTX
reported options exposure · as of Jun 30, 2026CallValue
$3,241,056
CallShares
68,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. DFTX ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in DFTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,365,923 | 50,296 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $3,241,056 | 68,900 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $750,007 | 39,683 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||